A randomized, double-blind, placebo-controlled phase 2 study of an oral p38α MAPK inhibitor, SCIO-469, in patients with active rheumatoid arthritis

被引：0

作者：

Genovese, M. C. ^{[1
]}

Cohen, S. B. ^{[2
]}

Wofsy, D. ^{[3
]}

Weinblatt, M. E. ^{[4
]}

Firestein, G. S. ^{[5
]}

Brahn, E. ^{[6
]}

Strand, V. ^{[7
]}

Baker, D. G. ^{[8
]}

Tong, S. E. ^{[9
]}

机构：

[1] Stanford Univ, Palo Alto, CA 94304 USA

[2] Metroplex Clin Res Ctr, Dallas, TX USA

[3] Univ Calif San Francisco, San Francisco, CA 94143 USA

[4] Brigham & Womens Hosp, Boston, MA 02115 USA

[5] Univ Calif San Diego, San Diego, CA 92103 USA

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Stanford Univ, Portola Valley, CA USA

[8] Centocor Inc, Malvern, PA 19355 USA

[9] Scios J&J PRD, Mountain View, CA USA

来源：

ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S431 / S432

页数：2

共 50 条

[21] Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study
Buondonno, Ilaria
Rovera, Guido
Sassi, Francesca
Rigoni, Micol Maria
Lomater, Claudia
Parisi, Simone
Pellerito, Raffaele
Isaia, Giovanni Carlo
D'Amelio, Patrizia
PLOS ONE, 2017, 12 (06):
[22] Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study
Tahir, Hasan
Deodhar, Atul
Genovese, Mark
Takeuchi, Tsutomu
Aelion, Jacob
Van den Bosch, Filip
Haemmerle, Sibylle
Richards, Hanno B.
RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 475 - 488
[23] Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study
Hasan Tahir
Atul Deodhar
Mark Genovese
Tsutomu Takeuchi
Jacob Aelion
Filip Van den Bosch
Sibylle Haemmerle
Hanno B. Richards
Rheumatology and Therapy, 2017, 4 : 475 - 488
[24] PRTX-100 and Methotrexate in Patients With Active Rheumatoid Arthritis: A Phase Ib Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study
Bernton, Edward
Gannon, William
Kramer, William
Kranz, Eduard
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 477 - 486
[25] EFFICACY AND TOLERABILITY OF A HOMEOPATHIC MEDICATION INCENA IN PATIENTS WITH RHEUMATOID ARTHRITIS (RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY)
Iaremenko, O.
Mykytenko, G.
Iaremenko, K.
Matiyaschuk, I.
Ivashkivsky, O.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 963 - 964
[26] TREATMENT OF ACTIVE RHEUMATOID-ARTHRITIS WITH SLOW INTRAVENOUS INJECTIONS OF THYMOPENTIN - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY
MALAISE, MG
FRANCHIMONT, P
BACHANDERSEN, R
GERBER, H
STOCKER, H
HAUWAERT, C
DANNESKIOLDSAMSOE, B
GROSS, D
GERSCHPACHER, H
BOLLA, K
LANCET, 1985, 1 (8433): : 832 - 836
[27] Efficacy of ixekizumab in patients with psoriatic arthritis: Results of a phase 3 randomized, double-blind, active- and placebo-controlled study
Mease, Philip
van der Heijde, Desiree
Ritchlin, Christopher
Cuchacovich, Rachel
Shuler, Catherine
Lin, Chen-Yen
Vangerow, Harald
Samanta, Suvajit
Lee, Chin
Gladman, Dafna
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
[28] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
Goodman, A. D.
Rossman, H.
Bar-Or, A.
Miller, A.
Miller, D. H.
Schmierer, K.
Lublin, F.
Khan, O.
Bormann, N. M.
Yang, M.
Panzara, M. A.
Sandrock, A. W.
NEUROLOGY, 2009, 72 (09) : 806 - 812
[29] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Deodhar, Atul
Gottlieb, Alice B.
Boehncke, Wolf-Henning
Dong, Bin
Wang, Yuhua
Zhuang, Yanli
Barchuk, William
Xu, Xie L.
Hsia, Elizabeth C.
LANCET, 2018, 391 (10136): : 2213 - 2224
[30] MAVRILIMUMAB IN RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2 DOUBLE-BLIND, PLACEBO CONTROLLED STUDY
Burmester, G.
Weinblatt, M.
McInnes, I.
Barbarash, O.
Esfandieri, E.
Sleeman, M.
Godwood, A.
Magrini, F.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 186 - 186

← 1 2 3 4 5 →